H-1B sponsorship profile: Viridian Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Viridian Therapeutics, Inc filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2025 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Viridian Therapeutics, Inc’s H-1B petitions range from $145,000 at the low end to $220,000 at the high end, with a petition-weighted average of $173,794. That range reflects the mix of occupations the company sponsors, led by Senior Manager, QC Tech Services Systems (1 petitions at $145,000 avg), followed by Director, R&D Quality PV and Clinical Trial Manager. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Viridian Therapeutics, Inc is headquartered in Waltham, MA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Viridian Therapeutics, Inc ranks. By H-1B petition volume, Viridian Therapeutics, Inc is #37,433 of 119,880 employers nationally and #1,704 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.